Discounted Cash Flow Rating

Neutral

Return on Equity Rating

Sell

Debt to Equity Rating

Neutral

Price to Earnings Rating

Strong Buy

Analyst Rating

Buy

Simple Moving Average

Strong Sell

Exponential Moving Average

Strong Sell

Relative Strength Index

Buy

Standard Deviation

Strong Buy

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Strong Buy

Wall Street Data Solutions Rating

Neutral

B

Keros Therapeutics, Inc. Common Stock (KROS)

Pharmaceutical Preparations

https://www.kerostx.com

Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cell counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.

1050 WALTHAM STREET, SUITE 302
LEXINGTON, MA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

04/08/2020

Market Cap

1,704,253,782

Shares Outstanding

33,460,000

Weighted SO

33,984,378

Total Employees

N/A

Upcoming Earnings

08/05/2024

Beta

1.2330

Last Div

0.0000

Range

27.02-73.0

Chg

-0.6200

Avg Vol

359019

Mkt Cap

1704253782

Exch

NASDAQ

Country

US

Phone

617 314 6297

DCF Diff

34.4874

DCF

10.7526

Div Yield

0.0000

P/S

6288.7593

EV Multiple

-7.2150

P/FV

3.8958

Div Yield %

0.0000

P/E

-9.7576

PEG

0.3857

Payout

0.0000

Current Ratio

20.3678

Quick Ratio

20.3678

Cash Ratio

19.1039

DSO

1811.5314

DIO

0.0003

Op Cycle

1811.5316

DPO

1727.2085

CCC

84.3231

Gross Margin

-4.0959

Op Margin

-696.1513

Pretax Margin

-620.1255

Net Margin

-620.1255

Eff Tax Rate

-0.0198

ROA

-0.3693

ROE

-0.4473

ROCE

-0.4349

NI/EBT

1.0000

EBT/EBIT

0.8908

EBIT/Rev

-696.1513

Debt Ratio

0.0307

D/E

0.0332

LT Debt/Cap

0.0296

Total Debt/Cap

0.0321

Int Coverage

0.0000

CF/Debt

-10.3032

Equity Multi

1.0810

Rec Turnover

0.2015

Pay Turnover

0.2113

Inv Turnover

999999.9999

FA Turnover

0.0143

Asset Turnover

0.0006

OCF/Share

-3.9831

FCF/Share

-4.0481

Cash/Share

11.2417

OCF/Sales

-530.6347

FCF/OCF

1.0163

CF Coverage

-10.3032

ST Coverage

-131.2062

CapEx Coverage

-61.2706

Div&CapEx Cov

-61.2706

P/BV

3.8958

P/B

3.8958

P/S

6288.7593

P/E

-9.7576

P/FCF

-11.6611

P/OCF

-11.4032

P/CF

-11.4032

PEG

0.3857

P/S

6288.7593

EV Multiple

-7.2150

P/FV

3.8958

DPS

0.0000

Latest Headlines (EST)

Revenue Product Segmentation